false
00000
0001094032
0001094032
2024-11-04
2024-11-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 4, 2024
QDM International Inc.
(Exact name of registrant as specified in its
charter)
Florida |
|
001-27251 |
|
59-3564984 |
(State or other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
Room 1030B, 10/F, Ocean Centre, Harbour City,
5 Canton Road, Tsim Sha Tsui, Kowloon, Hong Kong
+ 852 34886893
(Address and telephone number, including area
code, of registrant’s principal executive offices)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act: None.
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Jun Du as Director
On November 4, 2024, Jun Du
tendered her resignation as a Class III director of QDM International Inc. (the “Company”), effective immediately. Ms. Du’s
resignation was for personal reasons and was not due to any disagreement with the Company.
Appointment of Fawn Ren as Director of the
Company
To fill the vacancy created by Ms. Du’s resignation,
the board of directors of the Company (the “Board”) appointed Ms. Fawn Ren to serve as a Class III director of the Board,
effective as of November 6, 2024.
Fawn Ren, age 50, has more than 13 years’
experience in business consulting, management and financial services. Since September 2021, Ms. Ren has served as a Senior Manager at
international client services group at PwC Cyprus, a regional member firm of PricewaterhouseCoopers International Limited, a global professional
service group. From September 2018 to August 2021, Ms. Ren served as a Manager at private wealth group at PwC Cyprus. From December 2014
to August 2018, Ms. Ren was a Senior Associate I and II with private wealth group and assurance group at PwC Cyprus. From August 2011
to November 2014, Ms. Ren was an Associate with assurance and asset management group at PwC Boston. Ms. Ren holds a bachelor’s degree
in Economics from University of Iowa and a Master’s degree in Accounting from Bentley University.
Ms. Ren is entitled to an annual compensation of
$12,000 as a director pursuant to the director offer letter dated as of November 6, 2024, a copy of which is filed hereto as Exhibit 10.1
and incorporated by reference herein.
Ms. Ren has no family relationships with any director or executive officer
of the Company. There are no transactions between the Company and Ms. Ren that will be required to be reported pursuant to Item 404(a)
of Regulation S-K. To the knowledge of the Company, there is no understanding or arrangement between Ms. Ren and any other person pursuant
to which she was appointed as the Company’s director.
Item 9.01 Financial Statement and Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: November 7, 2024
|
QDM INTERNATIONAL INC. |
|
|
|
|
By: |
/s/ Huihe Zheng |
|
Name: |
Huihe Zheng |
|
Title: |
Chief Executive Officer |
2
Exhibit 10.1
QDM INTERNATIONAL INC.
November 6, 2024
Ms. Fawn Ren
Re: Offer Letter
Dear Ms. Ren:
QDM International Inc., a
Florida corporation (the “Company”, “we”, “us” or similar terminology), is pleased to offer you positions
as a member of its Board of Directors (the “Board”). We believe your background and experience will be a significant asset
to the Company and we look forward to your participation on the Board. Should you choose to accept the position as a member of the Board,
this letter agreement (the “Agreement”) shall constitute an agreement between you and the Company and contains all the terms
and conditions relating to the services you agree to provide to the Company.
1. Term. This
Agreement is effective as of the date of mutual execution of this Agreement (the “Effective Date”). Your term as director
of the Board shall continue subject to the Company’s Articles of Incorporation and Bylaws (each as amended and/or restated from
time to time) and the provisions in Section 9 below, until your successor is duly appointed and qualified. You shall stand for re-appointment
to the Board each year that the Class of Directors in which you serve is up for election at the annual stockholder’s meeting and
upon re-appointment, the terms and provisions of this Agreement shall remain in full force and effect. Notwithstanding the foregoing,
this Agreement may be terminated at any time in accordance with Section 9 hereto.
2. Services. You
shall render services as a member of the Board (hereinafter, your “Duties”). The Duties shall include those customary for
a board member of a public company whose securities are publicly traded in the United States. During the term of this Agreement, you shall
adhere to all applicable fiduciary duties and other laws, rules and regulations, and shall attend and participate in such number of meetings
of the Board as regularly or specially called. You may attend and participate at each such meeting, via teleconference, video conference
or in person. You shall consult with the other members of the Board (and the Company’s officers, as needed) regularly and as necessary
via telephone, electronic mail or other forms of correspondence.
3. Services for
Others. You shall be free to represent or perform services for other persons during the term of this Agreement. You
agree, however, that you do not presently perform and do not intend to perform, during the term of this Agreement, similar Duties, consulting,
or other services for companies whose businesses are or would be, in any way, competitive with the Company (except for companies previously
disclosed by you to the Company in writing). Should you propose to perform similar Duties, consulting, or other services for any such
company, you agree to notify the Company in writing in advance (specifying the name of the organization for whom you propose to perform
such services) and to provide information to the Company sufficient to allow it to determine if the performance of such services would
conflict with areas of interest to the Company.
4. Compensation.
a. Annual Cash Retainer. Commencing
on the Effective Date, you shall receive cash compensation of $12,000 for each calendar year of service under this Agreement on a pro-rated
basis, payable in arrears on a monthly basis, with the initial payment due November 31, 2024.
b. Reimbursement of Reasonable
Expenses. You shall also be reimbursed for reasonable, pre-approved expenses incurred by you in connection with the performance
of your Duties (including travel expenses for in-person meetings).
5. D&O Insurance
Policy. During the term under this Agreement, the Company shall include you as an insured under its officers and directors
insurance policy, if any.
6. No Assignment. Because
of the personal nature of the services to be rendered by you, this Agreement may not be assigned by you without the prior written consent
of the Company.
7. Confidential
Information; Non-Disclosure. In consideration of your access to certain Confidential Information (as defined below) of the
Company, in connection with your business relationship with the Company, you hereby represent and agree as follows:
a. Definition. For
purposes of this Agreement the term “Confidential Information” means: (i) any information which the Company possesses that
has been created, discovered or developed by or for the Company, and which has or could have commercial value or utility in the business
in which the Company is engaged; (ii) any information which is related to the business of the Company and is generally not known by non-Company
personnel; and (iii) Confidential Information includes, without limitation, trade secrets and any information concerning products, processes,
formulas, designs, inventions (whether or not patentable or registrable under copyright or similar laws, and whether or not reduced to
practice), discoveries, concepts, ideas, improvements, techniques, methods, research, development and test results, specifications, data,
know-how, software, formats, marketing plans, and analyses, business plans and analyses, strategies, forecasts, customer and supplier
identities, characteristics and agreements.
b. Exclusions. Notwithstanding
the foregoing, the term Confidential Information shall not include: (i) any information which becomes generally available or is readily
available to the public other than as a result of a breach of the confidentiality provisions of this Agreement, or any other agreement
requiring confidentiality between the Company and you; (ii) information received from a third party in rightful possession of such
information who is not restricted from disclosing such information; (iii) information known by you prior to receipt of such information
from the Company, which prior knowledge can be documented and (iv) information you are required to disclose pursuant to any applicable
law, regulation, judicial or administrative order or decree, or request by other regulatory organization having authority pursuant to
the law; provided, however, that you shall first have given prior written notice to the Company and made a reasonable effort to obtain
a protective order requiring that the Confidential Information not be disclosed.
c. Documents. You
agree that, without the express written consent of the Company, you will not remove from the Company’s premises, any notes, formulas,
programs, data, records, machines or any other documents or items which in any manner contain or constitute Confidential Information,
nor will you make reproductions or copies of same. You shall promptly return any such documents or items, along with any reproductions
or copies to the Company upon the Company’s demand, upon termination of this Agreement, or upon your termination or Resignation
(as defined in Section 9 herein).
d. Confidentiality. You
agree that you will hold in trust and confidence all Confidential Information and will not disclose to others, directly or indirectly,
any Confidential Information or anything relating to such information without the prior written consent of the Company, except as may
be necessary to perform your duties to the Company as a member of the Board. You further agree that you will not use any Confidential
Information without the prior written consent of the Company, except as may be necessary to perform your duties to the Company as a member
of the Board, and that the provisions of this paragraph (d) shall survive termination of this Agreement. Notwithstanding the foregoing,
you may disclose Confidential Information to your legal counsel and accounting advisors who have a need to know such information for accounting
or tax purposes and who agree to be bound by the provisions of this paragraph (d).
e. Ownership. You
agree that the Company shall own all right, title and interest (including patent rights, copyrights, trade secret rights, mask work rights,
trademark rights, and all other intellectual and industrial property rights of any sort throughout the world) relating to any and all
inventions (whether or not patentable), works of authorship, mask works, designations, designs, know-how, ideas and information made or
conceived or reduced to practice, in whole or in part, by you during the term of this Agreement and that arise out of your Duties (collectively,
“Inventions”) and you will promptly disclose and provide all Inventions to the Company. You agree to assist the Company, at
its expense, to further evidence, record and perfect such assignments, and to perfect, obtain, maintain, enforce, and defend any rights
assigned.
f. Survival. You
agree that the provisions of this Section 7 shall survive and remain in full force and effect upon and following any termination or purported
termination of this Agreement or from and after the time you cease performing services to the Company.
8. Non-Solicitation. During
the term of your appointment and for a period of one (1) year thereafter, you shall not solicit for employment any employee of the Company
with whom you have had contact due to your appointment. You agree that the provisions of this Section 8 shall survive and remain in full
force and effect upon and following any termination or purported termination of this Agreement or from and after the time you cease performing
services to the Company.
9. Termination
and Resignation. Your membership on the Board (which for purposes of this Agreement shall automatically mean any committee
of the Board) may be terminated and you may be removed from the Board for any or no reason by a vote of the stockholders holding at least
a majority of the shares of the Company’s issued and outstanding shares entitled to vote. In addition, the Board may, at any time
and for any reason, terminate this Agreement and all of your rights and benefits hereunder. You may also terminate your membership on
the Board for any or no reason by delivering your written notice of resignation to the Company (“Resignation”), and such
Resignation shall be effective upon the time specified therein or, if no time is specified, upon receipt of the notice of resignation
by the Company. Upon the effective date of any of the termination of your Board service, the termination of this Agreement or your Resignation,
your right to compensation hereunder will terminate subject to the Company’s obligations to pay you any compensation that you have
already earned and to reimburse you for approved expenses already incurred in connection with your performance of your Duties as of the
effective date of such termination or Resignation.
10. Governing
Law; Venue; Waiver of Jury Trial. All questions with respect to the construction and/or enforcement of this Agreement, and the
rights and obligations of the parties hereunder, shall be determined in accordance with the law of the State of Florida applicable to
agreements made and to be performed entirely in the State of Florida. The parties hereby irrevocably submit to the exclusive jurisdiction
of the state and federal courts sitting in the New York County, New York, for the adjudication of any dispute hereunder or in connection
herewith, and hereby irrevocably waive, and agree not to assert in any suit, action or proceeding, any claim that they are is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue
of such suit, action or proceeding is improper. THE PARTIES HEREBY IRREVOCABLY WAIVE ANY RIGHT EITHER MAY HAVE TO, AND AGREE NOT TO
REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION
CONTEMPLATED HEREBY.
11. Entire Agreement;
Amendment; Waiver; Counterparts. This Agreement expresses the entire understanding with respect to the subject matter hereof
and supersedes and terminates any prior oral or written agreements with respect to the subject matter hereof. Any term of this Agreement
may be amended and observance of any term of this Agreement may be waived only with the written consent of the parties hereto. Waiver
of any term or condition of this Agreement by any party shall not be construed as a waiver of any subsequent breach or failure of the
same term or condition or waiver of any other term or condition of this Agreement. The failure of any party at any time to require
performance by any other party of any provision of this Agreement shall not affect the right of any such party to require future performance
of such provision or any other provision of this Agreement. This Agreement may be executed in separate counterparts each of which
will be an original and all of which taken together will constitute one and the same agreement, and may be executed using facsimiles of
signatures, and a facsimile of a signature shall be deemed to be the same, and equally enforceable, as an original of such signature.
Delivery of such counterparts by facsimile or email/.pdf transmission shall constitute validity delivery thereof.
12. Indemnification.
The Company shall, to the maximum extent provided under applicable law, indemnify and hold you harmless from and against any expenses,
including reasonable attorney’s fees, judgments, fines, settlements and other legally permissible amounts (“Losses”),
incurred in connection with any proceeding arising out of, or related to, your performance of your Duties, other than any such Losses
incurred as a result of your fraud, willful default, gross negligence or willful misconduct. The Company shall advance to you any
expenses, including reasonable attorneys’ fees and costs of settlement, incurred in defending any such proceeding to the maximum
extent permitted by applicable law. Such costs and expenses incurred by you in defense of any such proceeding shall be paid by the
Company in advance of the final disposition of such proceeding promptly upon receipt by the Company of (a) written request for payment;
(b) appropriate documentation evidencing the incurrence, amount and nature of the costs and expenses for which payment is being sought;
and (c) an undertaking adequate under applicable law made by or on your behalf to repay the amounts so advanced if it shall ultimately
be determined pursuant to any non-appealable judgment or settlement that you are not entitled to be indemnified by the Company.
13. Not an Employment
Agreement. This Agreement is not an employment agreement, and shall not be construed or interpreted to create any right for
you to be employed by the Company.
14. Acknowledgement. You
accept this Agreement subject to all the terms and provisions of this Agreement. You agree to accept as binding, conclusive, and final
all decisions or interpretations of the Board of any questions arising under this Agreement.
Thank you for your agreement
to serve on our Board, and we look forward to working with you. If you are in agreement with the foregoing, please sign by your name below
and return a copy to me, which signature shall signify your agreement.
[Signature Page Follows]
The Agreement has been executed and delivered by
the undersigned and is made effective as of the date set first set forth above.
|
Sincerely, |
|
|
|
QDM International Inc. |
|
|
|
|
By: |
/s/ Huihe Zheng |
|
|
Name: Huihe Zheng |
|
|
Title: Chief Executive Officer and Chairman |
AGREED AND ACCEPTED: |
|
|
|
/s/ Fawn Ren |
|
Fawn Ren |
|
[Signature Page to Director Offer Letter]
4
v3.24.3
Cover
|
Nov. 04, 2024 |
Cover [Abstract] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Nov. 04, 2024
|
Entity File Number |
001-27251
|
Entity Registrant Name |
QDM International Inc.
|
Entity Central Index Key |
0001094032
|
Entity Tax Identification Number |
59-3564984
|
Entity Incorporation, State or Country Code |
FL
|
Entity Address, Address Line One |
Room 1030B
|
Entity Address, Address Line Two |
10/F, Ocean Centre, Harbour City
|
Entity Address, Address Line Three |
5 Canton Road, Tsim Sha Tsui
|
Entity Address, City or Town |
Kowloon
|
Entity Address, Country |
HK
|
Entity Address, Postal Zip Code |
00000
|
City Area Code |
852
|
Local Phone Number |
34886893
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
false
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 3 such as an Office Park
+ References
+ Details
Name: |
dei_EntityAddressAddressLine3 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionISO 3166-1 alpha-2 country code.
+ References
+ Details
Name: |
dei_EntityAddressCountry |
Namespace Prefix: |
dei_ |
Data Type: |
dei:countryCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14a -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
QDM (QB) (USOTC:QDMI)
Historical Stock Chart
From Feb 2025 to Mar 2025
QDM (QB) (USOTC:QDMI)
Historical Stock Chart
From Mar 2024 to Mar 2025